PHEAST
Live / Registered — Registered (as of 07 Jul 2026)
What this means for you
Registered since 07 Jul 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 07 Jul 2032: the §8 declaration of use).
Record
- Serial number
- 97295190
- Registration number
- 8335724
- Mark type
- Word mark
- Filed
- 04 Mar 2022
- Published for opposition
- 18 Apr 2023
- Registered
- 07 Jul 2026
- Next maintenance filing
- §8 declaration of use, due by 07 Jul 2032 (grace period to 07 Jan 2033)
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of cancer
Owner
- Pheast Therapeutics, Inc., Redwood City, CA, US
- Pheast Therapeutics, Inc., Redwood City, CA, US
- Pheast Therapeutics, Inc., Palo Alto, CA, US
Prosecution history
- 07 Jul 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Jul 2026 — REGISTERED-PRINCIPAL REGISTER
- 15 Jun 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 Jun 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 May 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 May 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 May 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 11 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 11 Feb 2026 — NON-FINAL ACTION E-MAILED
- 11 Feb 2026 — SU - NON-FINAL ACTION - WRITTEN
- 14 Jan 2026 — DATA MODIFICATION COMPLETED
- 14 Jan 2026 — ASSIGNED TO LIE
- 02 Jan 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 26 Jun 2025 — USE AMENDMENT FILED
- 02 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL